Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,161
Total Claims
$4.5M
Drug Cost
924
Beneficiaries
$4,877
Cost/Patient
Risk Score Breakdown 13/100
Score components are additive. Read full methodology
Peer Comparison vs. 9,082 Pulmonary Disease providers
-5%
Cost per patient vs peers
$4,877 vs $5,138 avg
-68%
Brand preference vs peers
19.5% vs 61.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.2%
Opioid Rate
33
Opioid Claims
$617
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,756 claims · $4.2M
Generic: 11,346 claims · $300K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Nintedanib Esylate | 127 | $1.8M |
| Fluticasone/Umeclidin/Vilanter | 414 | $355K |
| Alpha-1-Proteinase Inhibitor | 24 | $342K |
| Alpha-1-Proteinase Inhibitor | 25 | $197K |
| Edaravone | 12 | $155K |
| Apixaban | 103 | $82K |
| Fluticasone/Vilanterol | 152 | $77K |
| Budesonide/Formoterol Fumarate | 141 | $68K |
| Umeclidinium Brm/Vilanterol Tr | 97 | $64K |
| Sitagliptin Phosphate | 56 | $53K |
| Tiotropium Bromide | 59 | $41K |
| Tiotropium Br/Olodaterol Hcl | 66 | $39K |
| Rivaroxaban | 37 | $33K |
| Budesonide/Glycopyr/Formoterol | 41 | $33K |
| Ipratropium/Albuterol Sulfate | 46 | $28K |
Prescribing Profile
Patient Profile
73
Avg Age
59%
Female
1.83
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About